Research Article
Volume 4 Issue 3 - 2020
A Novel Therapeutic Approach for Treating Rett Syndrome
Aamir Jalal Al Mosawi1,2*
1Advisor in Pediatrics and Pediatric Psychiatry, Children Teaching Hospital of Baghdad Medical City, Baghdad, Iraq
2Head, Iraq Headquarter of Copernicus Scientists International Panel, Baghdad, Iraq
*Corresponding Author: Aamir Jalal Al Mosawi, Advisor in Pediatrics and Pediatric Psychiatry, Children Teaching Hospital of Baghdad Medical City and Head, Iraq Headquarter of Copernicus Scientists International Panel, Baghdad, Iraq.
Received: September 16, 2020; Publised: February 24, 2021


Background: Rett syndrome is a rare X-linked dominant neuro-developmental and pervasive developmental disorder that has no satisfactory or effective treatment. The diagnosis is generally clinical and autistic feature is a typical finding in all patients. We have previously described the short-term treatment of an Iraqi girl with Rett syndrome who was first seen at the age of about three years. The girl was treated with intramuscular cerebrolysin and oral citicoline for 40 days. Treatment was associated with significant improvement with the development of purposeful movement and the ability to hold feeding bottle with assistant of the mother and feed her. She was able to stand and step one step holding furniture. She started babbling and showed some reduction in the autistic features.

Aim of the Study: The aim of this paper is to describe the extended treatment of the girl with Rett syndrome which was treated with a novel therapeutic approach which included intramuscular cerebrolysin, citicoline, and piracetam.

Patients and Methods: After the initial 40 days treatment, the girl received several treatment courses that included intramuscular cerebrolysin, citicoline, and piracetam.

Results: Several months of treatment resulted in improvements in behavior, autistic features, and mobility and she was walking confidently holding a wall or furniture. Treatment was not associated with any side effects.

Conclusion: Rett syndrome is a very complex neuro-developmental and pervasive developmental disorder that has no satisfactory or effective treatment. The use of novel therapeutic approach which included intramuscular cerebrolysin, citicoline and piracetam for the treatment of Rett syndrome resulted in within few months a significant improvement that have not been reported without treatment or with any other therapies before.


Keywords: Rett Syndrome; Novel Treatment Approach


    1. Al-Mosawi AJ. “New therapies for Rett syndrome”. Journal of Bio Innovation3 (2019): 301-307.
    2. Al-Mosawi AJ. “Pervasive developmental disorders in Iraqi children”. Journal of Psychiatry Research Reviews AND Reports1 (2019): 1-8.
    3. Al-Mosawi AJ. “Pediatric psychiatry: An accredited training course”. 1st, Saarbrücken; LAP Lambert Academic Publishing (2018).
    4. Al-Mosawi AJ. “A new therapeutic approach for pervasive developmental disorders”. 1st edition., Saarbrücken; LAP Lambert Academic Publishing (2018).
    5. Al-Mosawi AJ. “The pattern of pervasive developmental disorders in Iraqi children”.1st edition., Saarbrücken; LAP Lambert Academic Publishing (2019).
    6. Al-Mosawi AJ. “The use of cerebrolysin and citicoline in autism and Asperger syndrome”. Journal of Bio Innovation 1 (2019): 99-108.
    7. Al-Mosawi AJ. “Our experience with childhood pervasive developmental disorders (Autism and Asperger Syndrome): Cure is Possible”. EC Clinical and Medical Case Reports 4 (2020): 01-08.
    8. Al-Mosawi AJ. “Cure of Autistic Disorders: Mission Impossible is Possible in an Illustrated Pioneering Experience”. Archives of Health Science 1 (2020):1-26.
    9. Al-Mosawi AJ. “Autism disorders: Cure is possible”. 1st edition, Saarbrücken; LAP Lambert Academic Publishing, Saarbrücken; Germany (2020).
    10. Al-Mosawi AJ. “Cure of autistic disorders: Our unique experience”. 1st edition., Saarbrücken; LAP Lambert Academic Publishing (2020).
    11. Al-Mosawi AJ. “Cura dei disturbi autistici: La nostra esperienza unica: Medicina basata sull'evidenza (Italian Edition)”. Edizioni Sapienza (2020).
    12. Al-Mosawi AJ. “Heilung von autistischen Störungen: Unsere einzigartige Erfahrung: Evidenzbasierte Medizin (German Edition)”. Verlag Unser Wissen (2020).
    13. Al-Mosawi AJ. “New Therapies for the treatment of spastic cerebral palsy”. Medical Journal of Clinical Trials and Case Studies 3.2 (2019): 1-9.
    14. Al-Mosawi AJ. “New Therapies for the treatment of ataxic cerebral palsy caused by kernicterus”. EC Clinical and Medical Case Reports 4 (2020): 26-31.
    15. Al-Mosawi AJ. “The use of intramuscular cerebrolysin and citicoline in the treatment of kernicterus”. Sun Krist Journal of Neonatology and Pediatrics 1 (2019):1-5.
    16. Al-Mosawi AJ. “The use of piracetam and cerebrolysin in the treatment of agenesis of corpus callosum with colpocephaly”. EC Clinical and Medical Case Reports 1 (2020): 01-05.
    17. Al-Mosawi AJ. “A Unique experience with mental and developmental retardation: Innovative Medical therapies for idiopathic mental retardation”. EC Clinical and Medical Case Reports 5 (2020): 42-54.
    18. Al-Mosawi AJ. “The Treatment of a Child with Birth Asphyxia Induced Brain Atrophy, Adrenal Hemorrhage, and Bi-lateral Hyperoxaluric Nephrocalcinosis: A Challenging Case and a Unique Experience”. Open Access Journal of Biogeneric Science and Research 2 (2020): 1-6.
    19. Al-Mosawi AJ. “Treatment of A Boy with idiopathic mental retardation: From uneducable to educable”. Progressing Aspects in Pediatrics and Neonatology5 (2020): 197-202.
    20. Al-Mosawi AJ. “Cerebral Palsy: A Unique Illustrated Experience”. Sun Krist Neurology, Neurosurgery and Stroke Journal1 (2020): 1-13.
    21. Al-Mosawi AJ. “Clinical uses of Cerebrolysin in Pediatric Neuropsychiatry”. Science World Journal of Pharmaceutical Sciences1 (2020): 1-4.
    22. Al-Mosawi AJ. “The Use of Citicoline in Pediatric Neurology and Pediatric Psychiatry”. Austin Pediatrics1 (2019): 1071-1072.
    23. Al-Mosawi AJ. “Recent Uses of Piracetam in Pediatric Neurology”. Sun Krist Neurology, Neurosurgery and Stroke Journal 2.1 (2020): 1-5.
Citation: Aamir Jalal Al Mosawi. “A Novel Therapeutic Approach for Treating Rett Syndrome”. EC Clinical and Medical Case Reports 4.3 (2021): 04-12.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 26, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to